in vitro diagnostics (ivd) market size, share, global trends and forecast 2013 - 2020

16
In Vitro Diagnostics Market

Upload: alliedmarketresearch

Post on 18-May-2015

218 views

Category:

Documents


3 download

TRANSCRIPT

In Vitro

Diagnostics

Market

I n t roduct i on

Scope of the Report Key Benefits Key Audiences

Descr i p t i on

In vitro diagnostics (IVD) is the technique of diagnostic test outside the human body in anartificial environment. The IVD market revenue is expected to reach $74.65 billion by 2020,from the market value of $53.32 billion in 2013, at a CAGR of 5.34% during 2014-2020. Theglobal IVD market is segmented based on techniques, product type, usability, application,end user and geography (North America, Europe, Asia Pacific and Rest of World).

Geographically, Asia Pacific is the fastest growing region and very opportune market thatwould generate highest revenue by 2020.Increase in the number of chronic and infectiousdiseases, and technological advancements are the major driving factors for the market.Widespread knowledge of healthcare & its benefits, and cost effectiveness are some topimpacting factors of the global IVD market.

The stringent regulatory policies and reimbursement issues are limiting the growth of themarket. Furthermore, the rising demand for technologically advanced diagnosis devices andincreased spending capabilities of consumers on health care provides huge potential for IVDin Asia Pacific market.

Assessments are made according to the current business scenario and the future market trendsare forecast for the period 2013-2020, with the base figures of the year 2013The analysis gives a wider view of the global market including its market trends, marketstructure, limiting factors and opportunities for the marketPorter’s five force’s model helps in analyzing the potential of buyers & suppliers, and thecompetitive sketch of the market, which would guide the market players to develop strategiesaccordinglyThe value chain analysis provides a systematic study on the key intermediaries involved, whichwould in turn help the stakeholders in the market to make appropriate strategiesThe advantages of the market are analyzed to help the stakeholders identify the opportunisticareas in a comprehensive manner

KEY BENEF I TS

I n V i t ro D i agnos t ic s Market Ana ly s i s

IVD Applications Market AnalysisThe application area is segmented based on infectious diseases, diabetes, cancer/oncology,cardiology, autoimmune diseases, nephrology, drug testing, HIV/AIDS and others. Infectiousdiseases generated the highest revenue for current and forecast period mainly due to rise in theincidences of infectious diseases. HIV/AIDS application market is the second largest revenuegenerating applications segment and would remain the second largest through 2020.

IVD End User Market AnalysisHospitals, laboratories, academics, point of care testing and others are the end users of global IVDmarket. Academic institutions provide trainings of IVD to the students. Laboratories generate thehighest revenue followed by point of care for global end user market. Rise in the number oflaboratories in Asia Pacific regions and increased awareness about health care and its benefits arecontributing towards the growth of laboratories market, which in turn drives the global IVD endusers market.

IVD Geography Market AnalysisThe detailed analysis of the global IVD market is done in various regions such as North America,Europe, Asia Pacific and Rest of World. North America is the largest revenue generating region in allsegments of global IVD market, whereas Asia Pacific region is fastest growing region amongst theregions studied.

I n V i t ro D i agnos t ic s Market Ana ly s i s

IVD Techniques Market AnalysisGlobal IVD techniques market is been segmented based on immunoassays, clinical chemistry,point of care, molecular diagnostics, hematology, coagulation, microbiology and other clinicaltechniques. Point of care is the highest revenue-generating segment in the overall IVD techniquesmarket. Molecular diagnostics is the fastest growing technique in the in the overall IVD techniquesmarket due to its ability to detect the primary cause of the disease accurately

IVD Product Type Market AnalysisThe product type segment is been segmented based on instruments, reagents, data managementsystems and services. Instruments hold the highest market share in the global IVD marketfollowed by reagents. Reagents market is also growing at a faster pace. As it is mostly used invarious equipment and play a key role in the overall diagnosis process. Rise in the usage ofdiagnostic devices in which reagents are required for performing diagnosis tests, is the majorfactor that drives the product type market.

IVD Usability Market AnalysisUsability segment is classified as disposable and reusable IVD devices. Doctors and clinicianscurrently prefer disposable devices, to avoid infections. Still, reusable IVD device holds the largestrevenue share in the global IVD usability market. Cost effectiveness as a benefit of reusabledevices is driving the growth of usability market.

IVD Market Compet i t i v e Ana ly s i s

& H i gh Lev e l Ana ly s i s

IVD Competitive AnalysisThe study of top ten players in the global market reveals strategies adopted to maintain theirposition in the competitive market. Strategic analysis of the top players reveals that marketplayers are adopting product launch as their key developmental strategy in the market, as themarket players are innovating novel products to expand their product line. Acquisitions andapprovals are some additional strategies adopted by the companies in the market to enhancetheir services and expand their reach across the globe.

IVD High Level AnalysisThe market exploration provides a clear view of global IVD market. Porter’s five-force model helpsin analyzing market players, new entrants in the market and the novel strategies adopted bythem. In the current business scenario, IVD market has moderate bargaining power of supplierdue to existence of brand loyalty. Varying product differentiation would lead to moderate buyers’bargaining. High entry barriers lead to lower threat of new entrants. Intersegment substitutionleads to lower threat of Substitute. The value chain analysis reveals the key intermediariesinvolved in the supply chain. Raw material suppliers, medical device manufacturers, distributors,service providers and end users are the various stakeholders involved in the supply chain of IVDmarket.

1. Introduction

2. Executive Summary

3. Market Overview

4. Global IVD Market by Techniques

5. Global IVD Market by Product Type

6. Global IVD Market by Usability

7. Global IVD Market by Application

8. Global IVD Market by End Users

9. Global IVD Market by Geography

10. Company Profiles

Tab le o f Cont ent s

Globa l In V i t ro D i agnos t ic s

Market Ov erv i ew

Market

dynamics

In Vitro

Diagnostics

Market

OverviewKey

technology

trends

Value chain

analysis

Market

Definition and

Scope

Key findings

Government

regulations

Porter five

forces model

Case studies

Market Dynamics

Key Market Drivers

Market Restraints

Unclear

reimbursement

policies

Market Dynami cs

Increasing

government

expenditures

on healthcare

Emergence of

minimal

invasive

technologies

Technological

advancements

in IVD

Increasing

incidences of

chronic and

infectious

diseases

Stringent

Regulatory

policies

IN V I TRO D IAGNOST IC S MARKET

BY END USER

IN VITRO

DIAGNOSTICS

MARKET

BY

END USER

Hospitals

Others

Laboratory

Academics

Point-of-Care Testing

Others

IN VITRO

DIAGNOSTIC

MARKET

BY

PRODUCT

TYPE

Instruments

Reagents

Data manage

ment system

Services

G L OBAL IN V I TRO D IAG NOS T IC S

MARKET BY PRODUCT TY PE

IN V I TRO D IAGNOST IC S MARKET

BY , TECHNIQUES

Hematology Clinical chemistry

CoagulationMolecular

diagnosticsMicrobiology

Immunoassay/

Immunochemistry

Infectious diseases Diabetes Cancer/Oncology Cardiology Autoimmune diseases Nephrology Drug testing HIV/AIDS Others

I n V i t ro D i agnos t ic s Market

by App l i cat i ons

Top Market P laye r s o f In V i t ro

D i agnos t ic s Market

Alerc Inc Biomerisux Danaher Corporation Roche Diagnostics Becton Dickinson and Company Bio-Rad Laboratories Abbott Laboratories Bayon AG Arkray Inc Sysmex Johnson & Johnson Siemens